Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer

Molecular Medicine Reports

Volumn 11, Issue 2, 2015, Pages 1004-1008

  Zhu, Yi ^a   Wu, Jian ^a   Li, Shiqi ^a   Wang, Xiao ^a   Liang, Zhen ^a   Xu, Xianglai ^a   Xu, Xin ^a   Hu, Zhenghui ^a   Lin, Yiwei ^a   Chen, Hong ^a   Qin, Jie ^a   Mao, Qiqi ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apigenin; Epithelial mesenchymal transition; Invasion; Motility; Prostate cancer

Indexed keywords

APIGENIN;

CELL CYCLE; CELL MOTION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MALE; NEOPLASM INVASIVENESS; PATHOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APIGENIN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84916220750     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2801     Document Type: Article

References (30)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Siegel R, DeSantis C, Virgo K, et al: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241, 2012.
3. American Cancer Society: Prostate cancer facts and statistics. http://www.cancer.org/cancer/prostatecancer/index. (Accessed on November 13, 2013).
4. Cook LS, Goldoft M, Schwartz SM and Weiss NS: Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 161: 152-155, 1999.
5. Arya M, Bott SR, Shergill IS, Ahmed HU, Williamson M and Patel HR: The metastatic cascade in prostate cancer. Surg Oncol 15: 117-128, 2006.
6. Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clini Lab Invest Suppl 50: 3-23, 1990.
7. Birt DF, Mitchell D, Gold B, Pour P and Pinch HC: Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17: 85-91, 1997.
8. Yang CS, Landau JM, Huang MT and Newmark HL: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21: 381-406, 2001.
9. Patel D, Shukla S and Gupta S: Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int J Oncology 30: 233-245, 2007.
10. Shukla S and Gupta S: Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther 5: 843-852, 2006.
11. Van Dross RT, Hong X and Pelling JC: Inhibition of TPA-induced cyclooxygenase-2 (COX-2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes. Mol Carcinog 44: 83-91, 2005.
12. Gupta S, Afaq F and Mukhtar H: Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun 287: 914-920, 2001.
13. Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33, 2009.
14. Caltagirone S, Rossi C, Poggi A, et al: Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87: 595-600, 2000.
15. Wang IK, Lin-Shiau SY and Lin JK: Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 35: 1517-1525, 1999.
16. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ and Birt DF: Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28: 102-110, 2000.
17. Yin F, Giuliano AE, Law RE and Van Herle AJ: Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res 21: 413-420, 2001.
18. Albini A, Iwamoto Y, Kleinman HK, et al: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
19. Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A and Balaji KC: Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 23: 402-406, 2005.
20. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
21. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
22. Sarkar FH, Li Y, Wang Z and Kong D: Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64: 489-500, 2009.
23. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W and van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119, 1991.
24. Bates RC and Mercurio AM: The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4: 365-370, 2005.
25. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
26. Branton MH and Kopp JB: TGF-beta and fibrosis. Microbes Infect 1: 1349-1365, 1999.
27. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW and Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66: 11271-11278, 2006.
28. Zhu Y, Mao Y, Chen H, et al: Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int 13: 54, 2013.
29. Lepley DM, Li B, Birt DF and Pelling JC: The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367-2375, 1996.
30. Lepley DM and Pelling JC: Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19: 74-82, 1997.